1. Home
  2. XYLO vs KTTA Comparison

XYLO vs KTTA Comparison

Compare XYLO & KTTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XYLO
  • KTTA
  • Stock Information
  • Founded
  • XYLO 1999
  • KTTA 2020
  • Country
  • XYLO Israel
  • KTTA United States
  • Employees
  • XYLO N/A
  • KTTA N/A
  • Industry
  • XYLO
  • KTTA Biotechnology: Pharmaceutical Preparations
  • Sector
  • XYLO
  • KTTA Health Care
  • Exchange
  • XYLO NYSE
  • KTTA Nasdaq
  • Market Cap
  • XYLO 3.1M
  • KTTA 3.2M
  • IPO Year
  • XYLO N/A
  • KTTA 2021
  • Fundamental
  • Price
  • XYLO $4.73
  • KTTA $2.48
  • Analyst Decision
  • XYLO
  • KTTA
  • Analyst Count
  • XYLO 0
  • KTTA 0
  • Target Price
  • XYLO N/A
  • KTTA N/A
  • AVG Volume (30 Days)
  • XYLO 16.2K
  • KTTA 43.9K
  • Earning Date
  • XYLO 09-20-2024
  • KTTA 11-13-2024
  • Dividend Yield
  • XYLO N/A
  • KTTA N/A
  • EPS Growth
  • XYLO N/A
  • KTTA N/A
  • EPS
  • XYLO N/A
  • KTTA N/A
  • Revenue
  • XYLO $57,642,000.00
  • KTTA N/A
  • Revenue This Year
  • XYLO $16.76
  • KTTA N/A
  • Revenue Next Year
  • XYLO $5.71
  • KTTA N/A
  • P/E Ratio
  • XYLO N/A
  • KTTA N/A
  • Revenue Growth
  • XYLO N/A
  • KTTA N/A
  • 52 Week Low
  • XYLO $2.70
  • KTTA $2.20
  • 52 Week High
  • XYLO $9.07
  • KTTA $9.25
  • Technical
  • Relative Strength Index (RSI)
  • XYLO 61.62
  • KTTA 38.84
  • Support Level
  • XYLO $4.19
  • KTTA $2.20
  • Resistance Level
  • XYLO $4.88
  • KTTA $2.61
  • Average True Range (ATR)
  • XYLO 0.49
  • KTTA 0.28
  • MACD
  • XYLO 0.04
  • KTTA -0.03
  • Stochastic Oscillator
  • XYLO 75.54
  • KTTA 24.35

About XYLO XYLO TECHNOLOGIES LTD

Xylo Technologies Ltd is an Israel-based medical device company. The company is engaged in the development, manufacturing, and marketing of direct vision systems for minimally invasive medical procedures and safety systems for drones and the electric vehicle (EV) sector. The key product of the company is the MUSE (Medigus Ultrasonic Surgical Endostapler) system is a single-use device for the incision-less treatment of GERD (gastroesophageal reflux disease), which is based on proprietary platform technology and know-how. The company operates in five segments namely, E-Commerce, Online Advertising & Internet Traffic Routing, Online Event Management, Corporate, and others. The company's geographical segments include the United States, Europe, Great Britain, Israel, Canada, Asia, and others.

About KTTA Pasithea Therapeutics Corp.

Pasithea Therapeutics Corp is a biotechnology company. It is focused on the discovery, research, and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies. It leveraging in the fields of neuroscience, translational medicine, and drug development. Its pipeline includes Neurofibromatosis Type 1, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), and Schizophrenia.

Share on Social Networks: